Announcement on Convening the 2025 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening the 2025 Semi-annual Performance Briefing
Filed with SSE · · 3 pages · Chinese
Release
Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd on 6ix
Earlier from Hangzhou Tianmushan Pharmaceutical Enterprise
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 15th Meeting of the 12th Board of Directors
- 2025 Semi-annual Report
- Announcement on Obtaining Notice of Approval for Re-Registration of Drug by the Subsidiary
- Announcement on Expected Increase in Semi-annual Performance for 2025
Later from Hangzhou Tianmushan Pharmaceutical Enterprise
- Announcement on Outline of the 2025 Semi-annual Performance Briefing
- Announcement on Reply to Letter from Shanghai Stock Exchange on Information Disclosure and Supervision
- Announcement on Renewal of Drug Production License
- Announcement on the Termination of the Original Lease Contract of the Subsidiary’s Property, Signing of a New Lease Contract, and the Related Party Transaction
- Announcement on Convening the Q3 2025 Performance Briefing
Follow Hangzhou Tianmushan Pharmaceutical Enterprise into a list and get an email when it puts out news.
Follow Hangzhou Tianmushan Pharmaceutical Enterprise